US Patent Reform Debate: Proposal To Eliminate BRI Patent Claim Standard Splits Stakeholders
Executive Summary
BIO and PhRMA want PTAB to give district courts deference in construing patent claims; Rep. Lofgren is concerned PTAB will be prohibited from doing its own claim construction and Mylan cites potential for inconsistencies within PTO.
You may also be interested in...
PTO Final Rule Dropping BRI Patent Claim Standard Offers No Deference To District Courts
Patent office may issue guidance on how PTAB will consider prior claim constructions; actions on other procedures may be coming in the 'near future.'
Despite Supreme Court Win, PTO Moves To Drop BRI Patent Claim Standard
US Patent and Trademark Office now agrees with patent owners that PTAB should use the same standard as district courts in determining the meaning of patent claim terms.
Supreme Court Upholds IPR Standard Making Patent Invalidation Easier; Will Congress Reverse?
High court says inconsistent decisions by Patent Trial and Appeal Board and district court are okay; House and Senate bills would eliminate the broad standard but opposition by tech community could doom passage.